Isolated cells (NAT-derived CD45+, NAT-derived CD45−, RCC-derived CD45+, RCC-derived CD45−, and PBMCs) from two patients were subjected to tryptic digestion and nano-LC–MS/MS analysis on an Orbitrap Lumos Fusion mass spectrometer. The gene discussed is PTPRC; the disease is renal cell carcinoma.